- Patent Title: Dosage and administration of non-fucosylated anti-CD40 antibodies
-
Application No.: US15522614Application Date: 2015-10-29
-
Publication No.: US11213584B2Publication Date: 2022-01-04
- Inventor: Shyra Gardai , Che-Leung Law , Stanford Peng , Jing Yang , Haley Neff-LaFord
- Applicant: Seagen Inc.
- Applicant Address: US WA Bothell
- Assignee: Seagen Inc.
- Current Assignee: Seagen Inc.
- Current Assignee Address: US WA Bothell
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2015/058108 WO 20151029
- International Announcement: WO2016/069919 WO 20160506
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61M25/00 ; A61K39/00
Abstract:
This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
Public/Granted literature
- US20170333556A1 DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES Public/Granted day:2017-11-23
Information query
